Lynne Uhl

Summary

Affiliation: Harvard University
Country: USA

Publications

  1. ncbi request reprint Detection of Staphylococcus aureus in peripheral blood stem cell cultures after sterilization of standard blood cultures
    Mitchell J Schwaber
    Department of Medicine, Division of Infectious Diseases, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA
    J Clin Apher 18:37-9. 2003
  2. ncbi request reprint Infectious risks of blood transfusion
    Lynne Uhl
    Yamins 309, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, MA 02215, USA
    Curr Hematol Rep 1:156-62. 2002
  3. pmc Vaccination with dendritic cell/tumor fusions following autologous stem cell transplant induces immunologic and clinical responses in multiple myeloma patients
    Jacalyn Rosenblatt
    Beth Israel Deaconess Medical Center, Boston, MA 02215, USA
    Clin Cancer Res 19:3640-8. 2013
  4. ncbi request reprint Utility of consecutive repeat HIT ELISA testing for heparin-induced thrombocytopenia
    Maren Chan
    Department of Pathology, Beth Israel Deaconess Medical Center, Boston, Massachusetts 02115, USA
    Am J Hematol 83:212-7. 2008
  5. ncbi request reprint Improved strategy for mononuclear cell collection for donor lymphocyte infusions
    Beth Shaz
    Department of Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts 02215, USA
    Transfusion 46:1044-8. 2006
  6. ncbi request reprint Individualized vaccination of AML patients in remission is associated with induction of antileukemia immunity and prolonged remissions
    Jacalyn Rosenblatt
    Beth Israel Deaconess Medical Center, Boston, MA 02215, USA
    Sci Transl Med 8:368ra171. 2016
  7. doi request reprint Provision of KEL1-negative blood to obstetric patients: a 3-year single-institution retrospective review
    Kerry L O'Brien
    Department of Pathology, Beth Israel Deaconess Medical Center, Boston, Massachusetts Department of Pathology, Harvard Medical School, Boston, Massachusetts
    Transfusion 55:599-604; quiz 598. 2015
  8. doi request reprint Anti-D alloimmunization after D-incompatible platelet transfusions: a 14-year single-institution retrospective review
    Kerry L O'Brien
    Department of Pathology, Beth Israel Deaconess Medical Center, Boston, Massachusetts
    Transfusion 54:650-4. 2014
  9. pmc Peripheral blood progenitor cell product contains Th1-biased noninvariant CD1d-reactive natural killer T cells: implications for posttransplant survival
    Angela Shaulov
    Department of Hematology Oncology Beth Israel Deaconess Medical Center, Boston, Mass 02215, USA
    Exp Hematol 36:464-72. 2008
  10. doi request reprint Risk of hemolytic transfusion reactions following emergency-release RBC transfusion
    Pamela P Goodell
    Dept of Pathology, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA
    Am J Clin Pathol 134:202-6. 2010

Collaborators

Detail Information

Publications16

  1. ncbi request reprint Detection of Staphylococcus aureus in peripheral blood stem cell cultures after sterilization of standard blood cultures
    Mitchell J Schwaber
    Department of Medicine, Division of Infectious Diseases, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA
    J Clin Apher 18:37-9. 2003
    ..Cultures of apheresis product may be more sensitive to the presence of bacteremia than standard blood cultures, and they should guide clinical decisions when the bacteria isolated are potential pathogens or suggest clinical infection...
  2. ncbi request reprint Infectious risks of blood transfusion
    Lynne Uhl
    Yamins 309, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, MA 02215, USA
    Curr Hematol Rep 1:156-62. 2002
    ..Consequently, investigative efforts that are even more vigorous are under way, aiming to define the characteristics of transmission as well as identify useful technologies to detect or eliminate these infectious agents...
  3. pmc Vaccination with dendritic cell/tumor fusions following autologous stem cell transplant induces immunologic and clinical responses in multiple myeloma patients
    Jacalyn Rosenblatt
    Beth Israel Deaconess Medical Center, Boston, MA 02215, USA
    Clin Cancer Res 19:3640-8. 2013
    ..We report on the results of a phase II trial in which patients underwent vaccination following autologous stem cell transplantation (ASCT) to target minimal residual disease...
  4. ncbi request reprint Utility of consecutive repeat HIT ELISA testing for heparin-induced thrombocytopenia
    Maren Chan
    Department of Pathology, Beth Israel Deaconess Medical Center, Boston, Massachusetts 02115, USA
    Am J Hematol 83:212-7. 2008
    ..Consecutive repeat ELISA testing for heparin antibodies may be warranted in patients with an increase in their pretest clinical score after an initial negative test as an adjunct to confirm the diagnosis of HIT...
  5. ncbi request reprint Improved strategy for mononuclear cell collection for donor lymphocyte infusions
    Beth Shaz
    Department of Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts 02215, USA
    Transfusion 46:1044-8. 2006
    ..To improve donor management for donor lymphocyte collections, a protocol was established to tailor the amount of whole blood processed during leukapheresis to achieve the requested cellular dose...
  6. ncbi request reprint Individualized vaccination of AML patients in remission is associated with induction of antileukemia immunity and prolonged remissions
    Jacalyn Rosenblatt
    Beth Israel Deaconess Medical Center, Boston, MA 02215, USA
    Sci Transl Med 8:368ra171. 2016
    ..The results demonstrate that personalized vaccination of AML patients in remission induces the expansion of leukemia-specific T cells and may be protective against disease relapse...
  7. doi request reprint Provision of KEL1-negative blood to obstetric patients: a 3-year single-institution retrospective review
    Kerry L O'Brien
    Department of Pathology, Beth Israel Deaconess Medical Center, Boston, Massachusetts Department of Pathology, Harvard Medical School, Boston, Massachusetts
    Transfusion 55:599-604; quiz 598. 2015
    ..We sought to determine compliance and impact for prevention of KEL1 alloimmunization and HDFN...
  8. doi request reprint Anti-D alloimmunization after D-incompatible platelet transfusions: a 14-year single-institution retrospective review
    Kerry L O'Brien
    Department of Pathology, Beth Israel Deaconess Medical Center, Boston, Massachusetts
    Transfusion 54:650-4. 2014
    ..We sought to retrospectively determine the rate of anti-D formation after D-incompatible apheresis PLT transfusions in those patients not receiving RhIG and not receiving D+ RBCs over a 14-year period at our institution...
  9. pmc Peripheral blood progenitor cell product contains Th1-biased noninvariant CD1d-reactive natural killer T cells: implications for posttransplant survival
    Angela Shaulov
    Department of Hematology Oncology Beth Israel Deaconess Medical Center, Boston, Mass 02215, USA
    Exp Hematol 36:464-72. 2008
    ..Recent data suggests that NKT might contribute to clinical benefits of PBPC...
  10. doi request reprint Risk of hemolytic transfusion reactions following emergency-release RBC transfusion
    Pamela P Goodell
    Dept of Pathology, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA
    Am J Clin Pathol 134:202-6. 2010
    ..4% ER episodes]) and receipt of antigen-incompatible RBCs (7/265 [2.6% ER episodes])...
  11. doi request reprint Identification and evaluation of false-negative antibody screens
    Amy Powers
    Department of Pathology, Beth Israel Deaconess Medical Center, Boston, Massachusetts 02215, USA
    Transfusion 50:617-21. 2010
    ..Data on the frequency of false-negative antibody screens due to the occurrence of these errors are scarce, and the true incidence of false-negative antibody screens in everyday practice is unknown...
  12. pmc Vaccination with dendritic cell/tumor fusion cells results in cellular and humoral antitumor immune responses in patients with multiple myeloma
    Jacalyn Rosenblatt
    Beth Israel Deaconess Medical Center, Boston, MA, USA
    Blood 117:393-402. 2011
    ..Vaccination with DC/multiple myeloma fusions was feasible and well tolerated and resulted in antitumor immune responses and disease stabilization in a majority of patients...
  13. ncbi request reprint Mitral-valve-induced microangiopathic hemolytic anemia
    J Nalinee Upalakalin
    Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA
    Transfusion 42:1105. 2002
  14. ncbi request reprint Do infections provoke exacerbations and relapses of thrombotic thrombocytopenic purpura?
    Christine M Cserti
    Harvard Joint Program in Transfusion Medicine Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA
    J Clin Apher 22:21-5. 2007
    ..A better understanding of the possible relationship between infection and clinical expression of TTP might lead to improved treatment decisions for patients with this complex illness...
  15. ncbi request reprint Cryoprecipitate. Patterns of use
    Liron Pantanowitz
    Department of Pathology, Division of Laboratory and Transfusion Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA
    Am J Clin Pathol 119:874-81. 2003
    ....
  16. doi request reprint Strict adherence to a blood bank specimen labeling policy by all clinical laboratories significantly reduces the incidence of "wrong blood in tube"
    Edward O'Neill
    Dept of Pathology, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA
    Am J Clin Pathol 132:164-8; quiz 306. 2009
    ..004%; P < or = .0001), respectively. During a short period, a simple, low-cost educational initiative and policy change can lead to statistically significant decreases in WBIT and mislabeled specimens received by the blood bank...